Synlett 2002(10): 1629-1632
DOI: 10.1055/s-2002-34232
LETTER
© Georg Thieme Verlag Stuttgart · New York

Highly Efficient Asymmetric Access to 1-Azaspiro[4.4]nonane Skeleton

Loïc Planasa, Joëlle Pérard-Vireta, Jacques Royer*a, Mohamed Selktib, Alain Thomasb
a Laboratoire de Chimie Thérapeutique, UMR 8638, CNRS-Université Paris 5, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France
Fax: +33(1)43291403; e-Mail: royer@pharmacie.univ-paris5.fr;
b Laboratoire de Cristallographie, UMR 8015, CNRS-Université Paris 5, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France
Further Information

Publication History

Received 31 July 2002
Publication Date:
23 September 2002 (online)

Abstract

Vinylogous Mukaiyama aldol type reaction of chiral non-racemic silyloxypyrroles followed by acidic treatment affords an efficient asymmetric access to 1-azaspiro[4.4]nonanes in high diastereoisomeric excess (up to 79%).

5

Typical Procedure for Silyloxypyrroles 5.
To a solution of 2,5-dimethoxy-2,5-dihydrofuran (1 equiv) and chiral amine 4a,c-e (1 equiv) in water (0.25 M) was added a concd solution of HCl (1.5 equiv). The mixture was stirred at r.t. for 3 h then neutralized with solid NaHCO3 and extract with CH2Cl2. The combined organic layers were dried over MgSO4 and the solvent distilled off. A red oil, mixture of the α,β and β,γ unsaturated lactams was then obtained. tert-Butyldimethylsilyl triflate (1 equiv) was slowly added to a solution of either the crude product or the purified lactams (1 equiv) and NEt3 (2 equiv) in CH2Cl2 (0.1 M) and the mixture was stirred at r.t. for 1 h. The solvent was evaporated under vacuum and the residue purified by filtration on a pad of alumina with a mixture of heptane and EtOAc. (Nota: silyloxypyrroles are used to be kept under argon at -20 °C). Analyses for 5d: [α]D 25 +11.7 (c 0.69, CH2Cl2). Mp = 97 °C (heptane-EtOAc). IR (KBr): ν = 2929, 2858, 1560, 1492, 1438 cm-1. 1H NMR (300 MHz, CDCl3): δ = -0.05 (s, 3 H), 0.23 (s, 3 H), 0.80 (s, 9 H), 1.89 (d, J = 7.0 Hz, 3 H), 5.31 (dd, J = 2.0, 3.6 Hz, 1 H), 6.01 (t, J = 3.5 Hz, 1 H), 6.16 (q, J = 7.0 Hz, 1 H), 6.35 (dd, J = 1.9, 3.4 Hz, 1 H), 7.10 (d, J = 7.2 Hz, 1 H), 7.42 (t, J = 7.9 Hz,
1 H), 7.50-7.55 (m, 2 H), 7.77 (d, J = 8.3 Hz, 1 H), 7.88 (d, J = 7.4 Hz, 1 H), 8.08 (d, J = 8.0 Hz, 1 H). 13C NMR
(75 MHz, CDCl3): δ = -5.0, -4.6, 18.2, 21.4, 25.7, 49.5, 87.7, 105.2, 109.8, 123.2, 125.8, 126.5, 128.1, 129.1, 131.0, 134.1, 139.7, 142.2. HRMS (CI, NH3): m/z calcd for C22H30NOSi (MH+): 352.2097. Found: 352.2101. Typical Procedure for Cyclobutanols 6. To a solution of silyloxypyrrole 5a-e (1 equiv) in anhyd CH2Cl2 (0.15 M) with 3Å MS, under argon, was added cyclobutanone (or cyclopentanone) (1.6 equiv). After 15 min at r.t., the solution was cooled at -78 °C and BF3·OEt2 (1.5 equiv) was added in the course of 15 min. The solution was stirred at -78 °C for 2 h and allowed to warm to 0 °C. The reaction was quenched by addition of H2O, the aq phase was separated and extracted with CH2Cl2. The organic phases were combined, dried over Na2SO4 and the solvent was removed under vacuum. The resulting oil was purified by flash chromatography.
Analyses for 6d: Minor diastereoisomer: [α]D 25 -264.1 (c 0.52, CHCl3). Mp = 245 °C (CH2Cl2). IR (KBr): ν = 3388, 2976, 2937, 1660 cm-1. MS (CI, NH3): m/z = 308 (MH+), 238 (MH+ - C4H6O). 1H NMR (300 MHz, CDCl3): δ = 0.35-0.5 (m, 1 H), 1.01 (s, 1 H, D2O exch.), 1.35-1.55 (m, 2 H), 1.55-1.70 (m, 2 H), 1.78 (d, J = 7.1 Hz, 3 H), 1.85-2.00 (m,
1 H), 4.25 (t, J = 1.6 Hz, 1 H), 6.30 (m, 2 H), 6.94 (dd, J = 7.0, 6.0 Hz, 1 H), 7.40-7.60 (m, 4 H), 7.83 (d, J = 8.1 Hz, 1 H), 7.90 (d, J = 8.3 Hz, 1 H), 8.23 (d, J = 8.4 Hz, 1 H). 13C NMR (75 MHz, DMSO): δ = 17.7, 24.4, 36.2, 40.6, 55.1, 74.8, 81.3, 128.5, 130.3, 130.8, 131.7, 132.9, 134.3, 134.5, 136.1, 139.0, 143.5, 151.3, 177.6. Major diastereoisomer: [α]D 25 -13.8 (c 0.97, CHCl3). Mp = 196-198 °C (Et2O). IR (KBr): ν = 3382, 2977, 2934, 1658, 1394 cm-1. MS (CI, NH3): m/z = 308 (MH+), 238 (MH+ - C4H6O). 1H NMR (300 MHz, CDCl3): δ = 1.36 (m, 1 H), 1.80-2.10 (m, 5 H), 1.75 (s, 1 H), 1.86 (d, J = 7.0 Hz, 3 H), 3.51 (t, J = 1.5 Hz, 1 H), 6.07 (q, J = 7.0 Hz, 1 H), 6.28 (dd, J = 1.6, 6.0 Hz, 1 H), 6.81 (dd, J = 1.8, 6.0 Hz, 1 H), 7.47 (m, 3 H), 7.63 (m, 2 H), 7.84 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 13.6, 19.1, 31.9, 36.2, 49.0, 69.6, 75.9, 123.2, 125.2, 125.8, 126.1, 127.3, 128.5, 129.1, 129.2, 132.0, 134.0, 136.2, 145.7, 173.3. Anal. Calcd for C20H21NO2: C, 78.15; H, 6.89; N, 4.56. Found: C, 78.03; H, 7.06; N, 4.60.

6

The crystal structure has been deposited at the Cambridge Crystallographic Data Centre; deposition number CCDC 180815.

8

Typical Procedure for Spiro Compounds 7.
To a solution of cyclobutanol 6a-e (1 equiv) in CH2Cl2 (0.05 M) was added concd aq HCl (1.5 equiv). After 9 h at 0 °C, the solvent was removed under vacuum. The crude product was redissolved twice in CH2Cl2 and reevaporated to eliminate trace amount of acid.
Analyses for 7d (cristallyzed from Et2O): [α]D 25 -48.4
(c 1.04, CHCl3). Mp = 140 °C (Et2O). IR (KBr): ν = 2968, 1750, 1679, 1380, 1347, 780 cm-1. MS (CI, NH3): m/z = 308 (MH+). 1H NMR (400 MHz, CDCl3): δ = 1.07-1.17 (m, 2 H), 1.34-1.55 (m, 2 H), 1.62 (ddd, J = 6.5, 8.5, 12.3 Hz,
1 H), 1.67 (d, J = 7.0 Hz, 3 H), 1.87 (ddd, J = 9.5, 11.6, 18.9 Hz, 1 H), 1.93 (ddd, J = 6.8, 8.9, 12.3 Hz, 1 H), 2.23 (dd, J = 6.1, 18.9 Hz, 1 H), 2.43 (dd, J = 6.8, 8.5, 16.8 Hz, 1 H), 2.53 (ddd, J = 6.5, 8.9, 16.8 Hz, 1 H), 6.25 (q, J = 7.1 Hz,
1 H), 7.30-7.60 (m, 4 H), 7.83 (d, J = 9.7 Hz, 1 H), 7.79 (d, J = 7.6 Hz, 1 H), 8.00 (d, J = 8.3 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ = 7.8, 18.9, 29.0, 31.7, 32.3, 35.7, 47.5, 72.3, 124.0, 125.1, 125.9, 126.3, 127.2, 129.1, 129.3, 132.7, 133.9, 136.1, 175.7, 217.0. Anal. Calcd for C20H21NO2: C, 78.15; H, 6.89; N, 4.56. Found: C, 77.96; H, 7.15; N, 4.41.